Characterization of free light chain impurity in a bispecific antibody
Bispecific antibodies (bsAbs) target two distinct binding sites, which enable novel mechanisms of action for the treatment of disease. Due to this structural complexity, bsAbs exhibit greater heterogeneity as compared to monospecific antibodies and may require nonstandard purification strategies to...
Saved in:
Main Authors: | Monica Sadek, Neelima Mantha, Steffen Lippold, Delia Li, Kyle Spitler, Ran Li, Phillip Spinosa, Bob Liu, Steven Luu, Nicholas Woon, Yeying Zhang, Jia Guo, Renee Yang, Jonathan Zarzar, Yi Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-12-01
|
Series: | mAbs |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/19420862.2025.2527689 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Possible Impurities in Radiopharmaceuticals and Corresponding Test Methods
by: G. E. Kodina, et al.
Published: (2022-10-01) -
Identification of tyrosine sulfation in the variable region of a bispecific antibody and its effect on stability and biological activity
by: Christopher B. Lietz, et al.
Published: (2023-12-01) -
Pharmacopoeial Requirements for Elemental Impurities in Radiopharmaceuticals (Review)
by: V. M. Shchukin, et al.
Published: (2023-08-01) -
Trends in industrialization of biotherapeutics: a survey of product characteristics of 89 antibody-based biotherapeutics
by: Kyle P. Martin, et al.
Published: (2023-12-01) -
Current approaches to the control of process-related impurities in antibiotics
by: E. L. Kovaleva, et al.
Published: (2024-12-01)